Author: John A. Wagner, MD, PhD on September 30, 2021 
You are missing out if you haven’t had the chance to read Christopher P. Austin’s “Opportunities and challenges in translational science” in Clinical and Translational Science (CTS). It is fitting that one of the world’s preeminent leaders in translational science published his opus of revelations from his years at National Center for Advancing Translational Sciences (NCATS) in CTS, a beacon for field the of translation medicine and science. Austin, an architect of NCATS, takes us on a journey to improve human health via a “bench to bedside” approach and then back to the bench again.
All is revealed in Austin’s thorough review, from the origins of the field through battling the Tower of Babel. Austin describes the mission of translational science as bringing predictivity and efficiency to the drug development and dissemination of interventions that improve human health. This approach has seen remarkable progress across a broad range of translational areas, from biomarker and drug development to clinical trials to implementation science to education. Austin also describes an ambitious but necessary future research agenda for the field.
The CTS editorial team invites you to submit your translational research to CTS. Whether your work highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease or is a bold new component of Austin’s future research agenda, please consider CTS for your next contribution.
The comment feature is locked by administrator.